IL-6 is elevated in the skin and blood of patients with localized scleroderma and SSc (35, 36) and was recently identified to be overexpressed by fibroblasts of patients with childhood-onset pansclerotic morphea (4). Here, IL6 is linked to systemic sclerosis.